Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
395.18
+7.86 (2.03%)
At close: Jun 26, 2026, 4:00 PM EDT
395.55
+0.37 (0.09%)
After-hours: Jun 26, 2026, 7:00 PM EDT
Elevance Health Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for Elevance Health stock have an average target of 415.3, with a low estimate of 331 and a high estimate of 498. The average target predicts an increase of 5.09% from the current stock price of 395.18.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Elevance Health stock from 22 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 12 |
| Buy | 4 | 3 | 3 | 3 | 3 | 2 |
| Hold | 7 | 8 | 8 | 8 | 7 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $480 | Buy | Maintains | $480 | +21.46% | Jun 11, 2026 |
| Bernstein | Bernstein | Buy Maintains $424 | Buy | Maintains | $424 | +7.29% | Jun 9, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $411 → $476 | Buy | Maintains | $411 → $476 | +20.45% | Jun 8, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $435 → $465 | Buy | Maintains | $435 → $465 | +17.67% | Jun 8, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $391 | Buy | Maintains | $391 | -1.06% | Jun 4, 2026 |
Financial Forecast
Revenue This Year
194.30B
from 199.13B
Decreased by -2.42%
Revenue Next Year
198.71B
from 194.30B
Increased by 2.27%
EPS This Year
26.90
from 30.29
Decreased by -11.18%
EPS Next Year
29.25
from 26.90
Increased by 8.71%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 197.9B | 206.3B | |
| Avg | 194.3B | 198.7B | |
| Low | 190.0B | 193.9B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.6% | 6.2% | |
| Avg | -2.4% | 2.3% | |
| Low | -4.6% | -0.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 28.25 | 31.00 | |
| Avg | 26.90 | 29.25 | |
| Low | 26.72 | 28.64 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -6.7% | 15.2% | |
| Avg | -11.2% | 8.7% | |
| Low | -11.8% | 6.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.